Bitcoin Dips Below $19,000; Here Are The Top Crypto Movers For Wednesday
Bitcoin (CRYPTO: BTC), the world’s most valued cryptocurrency, traded lower, dropping below the $19,000 level this morning.
Bitcoin Jumps Above This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar Today
Bitcoin (CRYPTO: BTC), the world’s most valued cryptocurrency, traded higher, surpassing the major $20,000 level this morning.
Turnaround For This Cancer Genetics Testing Firm Could Take Years, Analyst Says While Downgrading Stock
Needham has downgraded NeoGenomics Inc (NASDAQ:NEO) from Buy to Hold, citing that NEO’s turnaround will likely take several years and believes…
Needham Downgrades NeoGenomics to Hold
Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.
NeoGenomics: Q2 Earnings Insights
NeoGenomics (NASDAQ:NEO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 12, 2022
Companies Reporting Before The Bell
• NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.
Morgan Stanley Maintains Equal-Weight on NeoGenomics, Lowers Price Target to $18
Morgan Stanley analyst Tejas Savant maintains NeoGenomics (NASDAQ:NEO) with a Equal-Weight and lowers the price target from $19 to $18.
Needham Maintains Buy on NeoGenomics, Lowers Price Target to $16
Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and lowers the price target from $19 to $16.